trimethoprim+sulfamethoxazole 160+800 mg orally, 12-hourly, PLUS,
folic acid 5 mg orally, daily.
Treatment is recommended until 32 weeks' gestation, even if the patient has spontaneously recovered, to prevent fetal and maternal complications. Seek expert advice for the management of pregnant women beyond 32 weeks gestation.
Although trimethoprim + sulfamethoxazole can cause congenital abnormalities when used during pregnancy, the potential benefits of treatment outweigh the potential harms. The concomitant use of folic acid reduces the risk of congenital abnormalities.